The spotlight continues to shine on the benefits of omega-3 fatty acids from fish/fish oils and the EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) content. These fats possess cardioprotective properties. They support brain and nervous system health, vision and mood, and function as anti-inflammatories. Research shows regular EPA/DHA intake can help reduce rheumatoid arthritis, inflammatory bowel disease (Crohn’s), inflammatory skin conditions (psoriasis, atopic dermatitis) and triglycerides.
Dr Dariush Mozaffarian from the Harvard School Public Health Program in Cardiovascular Epidemiology suggests that fish oil and omega 3’s are the first line of treatment for primary prevention of cardiac death. Studies show that there is a 36% risk reduction in sudden cardiac death @ 250mg – 500mg day (EPA/DHA).
Scientists have now completed a comprehensive review of various studies on the benefits of these omega 3 fats (EPA/DHA) and are now recommending a creation of a DRI to help reduce the risk of heart disease.
Check out the article on the following link from nutraingredients.com
http://www.nutraingredients.com/On-your-radar/Omega-3/Omega-3-science-review-supports-DRI-for-heart-benefits
Comments